NCT00544271View on ClinicalTrials.gov

Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.

PHASE4TerminatedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

January 31, 2004

Conditions
Acellular PertussisTetanusDiphtheria
Interventions
BIOLOGICAL

INFANRIX

BIOLOGICAL

BOOSTRIX

BIOLOGICAL

HAVRIX

Trial Locations (1)

3053

GSK Investigational Site, Carlton

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY